PRKAR1AandPDE4DMutations Cause Acrodysostosis but Two Distinct Syndromes with or without GPCR-Signaling Hormone Resistance
Author(s) -
Agnès Linglart,
Helena Fryssira,
Olaf Hiort,
Paul-Martin Holterhus,
Guiomar Pérez de Nanclares,
Jesús Argente,
Claudine Heinrichs,
Alma Kuechler,
Giovanna Mantovani,
Bruno Leheup,
Philippe Wicart,
Virginie Chassot,
Dorothée Schmidt,
Oscar RubioCabezas,
Annette Richter-Unruh,
Sara Berrade,
Arrate Pereda,
Emese Boros,
M.T. Muñoz-Calvo,
Marco Castori,
Yasemin Güneş,
Guylène Bertrand,
Pierre Bougnères,
Éric Clauser,
Caroline Silve
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2326
Subject(s) - mutation , phenotype , biology , genetics , g protein coupled receptor , cancer research , signal transduction , gene
Acrodysostosis is a rare skeletal dysplasia that is associated with multiple resistance to G protein-coupled receptor (GPCR) signaling hormones in a subset of patients. Acrodysostosis is genetically heterogeneous because it results from heterozygous mutations in PRKAR1A or PDE4D, two key actors in the GPCR-cAMP-protein kinase A pathway.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom